Inflammation, cancer, and bone loss
- 2 July 2009
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Pharmacology
- Vol. 9 (4), 427-433
- https://doi.org/10.1016/j.coph.2009.06.007
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Breast cancer bone metastasis and current small therapeuticsCancer and Metastasis Reviews, 2006
- Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destructionThe Journal of Experimental Medicine, 2006
- NF‐κB and cancer: Mechanisms and targetsMolecular Carcinogenesis, 2006
- Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activationNature, 2006
- Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2Clinical Cancer Research, 2006
- Rheumatic diseases: the effects of inflammation on boneImmunological Reviews, 2005
- New Insights in the Mechanism of Bone Loss in ArthritisCurrent Pharmaceutical Design, 2005
- Advances in osteoclast differentiation and function.Current Drug Target - Immune, Endocrine & Metabolic Disorders, 2005
- MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKLCancer Cell, 2005
- NEMO Mutations in 2 Unrelated Boys With Severe Infections and Conical TeethPublished by American Academy of Pediatrics (AAP) ,2005